Physician profile
Eric N Thai
NPI 1649210873
$7,088.22
in general payments reported to CMS, 2019-2025
23 companies · $819 in 2025
The $819 reported for 2025 was more than what 88% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,048 · 2020: $285 · 2021: $404 · 2022: $1,378 · 2023: $2,621 · 2024: $535 · 2025: $819.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,804 · Entertainment: $170.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,804.40 |
| Entertainment | $170.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lumenis Be INC | $1,622.94 | 2023 | Optilight |
| Johnson & Johnson Vision Care, INC. | $1,238.52 | 2019-2025 | Acuvue |
| Alcon Vision LLC | $558.18 | 2019-2025 | Precision 1, Precision7 |
| Bausch & Lomb Americas INC. | $538.18 | 2022-2025 | Infuse, Infuse Multifocal |
| Optos, INC. | $485.38 | 2019-2025 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Allergan, INC. | $363.30 | 2019-2022 | |
| Carl Zeiss Meditec, INC. | $249.69 | 2019 | |
| Dompe US, INC. | $237.50 | 2024-2025 | Oxervate |
| Glaukos Corporation | $220.00 | 2023-2024 | Kxl1b-Ce-Marked Kxlsystem, Kxl System (Not Refurbished), Ce-Marked Kxla System |
| Genentech USA, INC. | $196.27 | 2019-2022 | |
| Sun Pharmaceutical Industries INC. | $147.59 | 2019-2022 | |
| Tarsus Pharmaceuticals, INC. | $145.52 | 2024-2025 | Xdemvy |
| Biotissue Holdings INC. | $141.15 | 2023 | |
| Rxsight INC | $135.83 | 2022 | |
| Oyster Point Pharma, INC. | $135.53 | 2022-2023 | Tyrvaya |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopervision INC. | $133.79 | 2022-2025 | Misight Contact Lens |
| Harrow Eye, LLC | $121.64 | 2025 | Vevye |
| Johnson & Johnson Surgical Vision, INC. | $117.65 | 2024 | Tecnis Simplicity, Tecnis Iol, Veritas Vision System |
| Novartis Pharmaceuticals Corporation | $100.00 | 2020 | |
| Astellas Pharma US INC | $96.57 | 2023-2024 | Izervay |
| Abbvie INC. | $68.84 | 2022 | |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Maculogix, INC. | $14.75 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Thai listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.